As a result of the fact that the human leucocyte antigen (HLA) system is inherited
independently from the ABO-blood group system, approximately 40–50% of all …

We have designed a protocol for ABO-incompatible kidney transplantations based on
preoperative plasmapheresis with a tacrolimus/mycophenolate mofetil/methylprednisolone …

Immune-mediated hemolysis is a well-recognized occurrence which complicates the period
following a bone marrow transplant (BMT). However, although many studies have …

Bone marrow transplantation results in the infusion of 150 to 360 ml of erythrocytes. While
this poses no problem to a recipient of marrow from an ABO‐compatible donor, it clearly …

Background. Major ABO-incompatibility can be associated with haemolysis, prolonged red
cell aplasia (PRCA) and higher peri-transplant mortality resulting from organ toxicity after …

BACKGROUND: Major ABO incompatibility of a bone marrow donor and recipient entails the
risk of severe hemolytic transfusion reactions. STUDY DESIGN AND METHODS: Nineteen …

About 10–15 percent of all patients undergoing allogeneic bone marrow transplantation
have a major ABO-incompatibility with their donors. The risk of acute hemolytic reactions …

We report a case of mild, clinically asymptomatic, immune thrombocytopenia after allogenic
bone marrow transplantation (BMT) for chronic myeloid leukemia (CML) caused by the …

Background Immune hemolytic anemia is a well‐known complication after allogeneic
hematopoietic stem cell transplantation (HSCT). Posttransplant hemolytic anemia results in …

Introduction ABO compatible non-identical kidney transplants are used frequently. Acquired
hemolytic anemia has been reported after ABO mismatched transplantation. Patients of A, B …